Medtronic Bridge X3
This article was originally published in The Gray Sheet
Executive SummaryRenal stent system gains CE mark approval for European marketing. Indicated for the treatment of atherosclerotic disease in the renal arteries, the device has a 6 Fr crossing profile and high radial strength to withstand the elastic recoil found in renal arteries, the company claims. The stent has an unexpanded length of 17 mm and comes in diameters of 5, 6, and 7 mm. The balloon catheter used to deliver the stent comes in lengths of 75 and 120 cm. A version of the system with the same name for the biliary tract is set to be unveiled the week of June 12, according to the company
You may also be interested in...
A patent-litigation settlement that Teva has reached with Ironwood and Allergan over Linzess will allow the Israeli firm to enter the US market with the linaclotide-based constipation treatment ahead of major rivals Mylan, Sandoz, Sun Pharma and Aurobindo.